MPA: a treatment option for lymphocytic colitis and mesalamine-induced interstitial nephritis

Inflamm Bowel Dis. 2012 Mar;18(3):E599-600. doi: 10.1002/ibd.21705. Epub 2011 Dec 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Colitis, Lymphocytic / complications
  • Colitis, Lymphocytic / drug therapy*
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Male
  • Mesalamine / adverse effects
  • Middle Aged
  • Mycophenolic Acid / therapeutic use*
  • Nephritis, Interstitial / chemically induced
  • Nephritis, Interstitial / complications
  • Nephritis, Interstitial / drug therapy*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Enzyme Inhibitors
  • Mesalamine
  • Mycophenolic Acid